Loading clinical trials...

Efficacy and Safety of Atacicept in IgA Nephropathy | Clinical Trials | Clareo Health

TERMINATEDPhase 2NCT02808429

Efficacy and Safety of Atacicept in IgA Nephropathy

This main purpose of this study was to evaluate the safety, tolerability, dose response and efficacy of Atacicept in participants with IgA nephropathy and persistent proteinuria. The study hypothesis ...

Lead sponsor: EMD Serono Research & Development Institute, Inc.•16 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 3

A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression

NCT05797610 · Primary IgA Nephropathy

RECRUITINGPhase 1

CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease

NCT07305116 · Autoimmune Diseases, Systemic Lupus Erthematosus (SLE), and more

RECRUITINGPhase 3

A Trial of HRS-5965 Capsule in Primary IgA Nephropathy

NCT07014826 · Primary IgA Nephropathy

RECRUITING

Study of the Link Between Complement Activation and IgA Nephropathy Severity

NCT05234463 · IgA Nephropathy Severity in Kidney Transplantation

RECRUITINGPhase 2

Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue

NCT06740526 · IgA Nephropathy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 25, 2021Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment16

Start dateJan 2017

Last updatedFeb 25, 2021

Condition

IgA Nephropathy

Locations shown

AKDHC Medical Research Services, LLC.

Glendale, Arizona

California Institute of Renal Research - Chula Vista Location

Chula Vista, California

Colorado Kidney Care PC - Dr. Marder

Denver, Colorado

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 25, 2021Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions